Ipratropium and mydriasis Patient Reports February 13, 2012

Ipratropium Side Effects Report #5172153-1
Ipratropium side effect was reported by a Consumer or non-health professional from on Dec 06, 2006. Female patient, 78 years of age, was diagnosed with wheezing, respiratory failure and was treated with Ipratropium. After drug was administered, patient experienced the following side effects: medical device complication, mental status changes, mydriasis, pupils unequal, reversible posterior leukoencephalopathy syndrome. Ipratropium dosage: unknown. During the same period patient was treated with IPRATROPIUM BROMIDE, LEVALBUTEROL. Patient recovered.

Ipratropium Side Effects Report #5131695-5
Ipratropium side effect was reported by a Consumer or non-health professional from on Oct 20, 2006. Male patient, child 10 years of age, weighting 66.14 lb, was diagnosed with status asthmaticus and was treated with Ipratropium. After drug was administered, patient experienced the following side effects: blood ph decreased, bradycardia, condition aggravated, dyspnoea, mean arterial pressure decreased, mydriasis, oxygen saturation decreased, pco2 increased, po2 increased. Ipratropium dosage: unknown. During the same period patient was treated with SALBUTAMOL. Patient recovered.

Ipratropium Side Effects Report #4750146-3
Ipratropium side effect was reported by a Consumer or non-health professional from on Aug 15, 2005. Female patient, 82 years of age, was diagnosed with bronchitis acute and was treated with Ipratropium. After drug was administered, patient experienced the following side effects: angle closure glaucoma, eye pain, mydriasis. Ipratropium dosage: unknown. During the same period patient was treated with ALBUTEROL SULPHATE HFA, METHYLPREDNISOLONE, CEFTRIAXONE. Patient recovered.

Ipratropium Side Effects Report #5663843-2
Ipratropium side effect was reported by a Physician from AUSTRALIA on Feb 28, 2008. Female patient, 22 years of age, was treated with Ipratropium. After drug was administered, patient experienced the following side effects: accommodation disorder, asthenopia, feeling abnormal, iiird nerve paralysis, medical device complication, mydriasis, pupillary reflex impaired. Ipratropium dosage: 1 ML; NEB_SOL; INH; Q6H. During the same period patient was treated with SALBUTAMOL, VITAMINS, PANCREASE. Patient was hospitalized. Patient recovered.